Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial.
Hitoshi IshiiBrian B HansenJakob LangerHiroshi HorioPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
ClinicalTrials.gov NCT03015220.